Advisory Services Network’s Day One Biopharmaceuticals DAWN Stock Holding History

Advisory Services Network’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11	Closed	-$236	–	2741
2026 Q1	$236	Buy	+11	New	+$155	﹤0.01%	4538
2025 Q4	–	Sell	-11	Closed	-$78	–	2380
2025 Q3	$78	Buy	+11	New	+$76	﹤0.01%	4406

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Advisory Services Network's DAWN Position: Q2 2026 in Review

Advisory Services Network sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 11 shares — an estimated $236 sold.

Advisory Services Network first reported a position in DAWN in Q3 2025 and held it in 2 quarters. The position peaked at $236 in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Advisory Services Network reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 11 Day One Biopharmaceuticals shares in Q2 2026, an estimated $236.
Advisory Services Network first reported a position in Day One Biopharmaceuticals in Q3 2025 and held it in 2 quarters.
Advisory Services Network's Day One Biopharmaceuticals position peaked at $236 in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.